Skip to content

Perioperative Fluid Therapy Optimization in Spinal Surgery

Perioperative Fluid Therapy Optimization in Spinal Surgery Using Non-invasive Measurement of Haemodynamics (ClearSight System, Edwards); a Comparison to Standard Method

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03644654
Enrollment
100
Registered
2018-08-23
Start date
2018-08-21
Completion date
2020-07-30
Last updated
2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypovolemia, Hypervolemia

Keywords

fluid responsiveness, haemodynamical monitoring, ClearSight

Brief summary

The decision to give fluids perioperatively could be based on methods used to identify preload responsiveness, either invasive or noninvasive estimates of stroke volume variation during mechanical ventilation. This study compares fluid management using continuous noninvasive cardiac output measurement with standard perioperative fluid management.

Detailed description

The aim of the study is to optimise fluid managemet and to reduce perioperative risks during spinal procedures in prone position. Adequate perioperative management guided by hemodynamic monitoring can help to reduce the risk of complications and thus potentially improve outcomes.

Interventions

Patient will receive 2 ml/kg/hour of crystalloids (Ringerfundin BBraun) intraoperatively. Fluid boluses will be used according to anesthesiologists decision (timing and amount of fluids). In case of drop of mean arterial pressure (MAP) below 65 mmHg norepinephrine will be started (with initial bolus of 5 - 10 ug).

PROCEDURENoninvasive monitoring group

Patient will receive 2 ml/kg/hour of crystalloids (Ringerfundin BBraun) intraoperatively. In case of hypotension (defined as a mean arterial pressure below 65 mmHg), the intervention will be led according to a protocol based on cardiac index, systemic vascular resitance and stroke volume variation (SVV) values (ClearSight, Edwards).

Sponsors

University Hospital Hradec Kralove
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Glasgow Coma scale 15 * ASA Physical Status Classification System I-III * planed spinal surgery to 3 hours * postoperative awakening * sinus rhythm

Exclusion criteria

* NYHA III, IV * BMI over 40 in females and over 35 in men * awake operation * postoperative artificial ventilation

Design outcomes

Primary

MeasureTime frameDescription
intraoperative fluid balance5 hoursthe difference between fluid intake and output and losses during surgery

Secondary

MeasureTime frameDescription
level of creatinine24 hoursplasma level of creatinine measured on the first postoperative day
mean dose of norepinephrine5 hoursmean dose of norepinephrine wil be calculated as total intraoperative norepinephrine dose devided by the lenght of surgery
pooperative lung dysfunction24 hourspostoperative lung dysfunction defined as SpO2 value less than 92% or oxygen therapy for more than 6 hours postoperatively
the length of postoperative staytill 2 months after surgerythe length of postoperative stay in hospital

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026